10-K Decoder · All companies

Fennec Pharmaceuticals Inc.

FENC · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$44.6M$47.5M−6.1%
Operating income−$6.28M$2.57M
Net income−$9.74M−$440K−2,114%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 12, 2026

$Q3 2026Year earlierChange
Revenue$19.6M$12.5M+56.8%
Operating income$4.70M−$200K
Net income$4.60M−$600K

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Fennec's revenue in FY2025?
$44.6M in FY2025 (Fiscal year ended Dec 31, 2025), −6.1% vs $47.5M a year earlier, per its 10-K filed Mar 2026.
Was Fennec profitable in FY2025?
No: net income was −$9.74M and operating income −$6.28M in FY2025.
What was Fennec's revenue in Q3 2026?
$19.6M (+56.8% vs a year earlier), per its Form 10-Q filed Nov 12, 2026.